This panel will explore the opportunities and hurdles in the dynamic field of advanced biologics manufacturing, where innovative technologies intersect with medical advancements. This domain offers significant opportunities, including the development of revolutionary treatments and life-saving interventions. However, it also presents substantial challenges for researchers, biopharma drug manufacturers, critical material suppliers, and regulators, necessitating the navigation of complex scientific and technological landscapes. Speakers will delve into both the promising prospects and the hurdles facing this rapidly evolving space.